Dr. Ellisen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Grj 904
Boston, MA 02114Phone+1 617-724-1399Fax+1 617-726-8623
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1994 - 1997- Brigham and Women's HospitalResidency, Internal Medicine, 1992 - 1994
Stanford University School of MedicineClass of 1992
Certifications & Licensure
MA State Medical License 1994 - 2025
Publications & Presentations
PubMed
- 85 citationsFGFR2 signaling underlies p63 oncogenic function in squamous cell carcinomaMatthew R. Ramsey, Catherine Wilson, Benjamin Ory, S. Michael Rothenberg, William C. Faquin
The Journal of Clinical Investigation. 2013-08-01 - 53 citationsMcl-1 and FBW7 control a dominant survival pathway underlying HDAC and Bcl-2 inhibitor synergy in squamous cell carcinomaLei He, Kristine Torres-Lockhart, Nicole Forster, Saranya Ramakrishnan, Patricia Greninger
Cancer Discovery. 2013-03-01 - 284 citationsUnravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seqMihriban Karaayvaz, Simona Cristea, Shawn M. Gillespie, Anoop P. Patel, Ravindra Mylvaganam
Nature Communications. 2018-09-04
Press Mentions
Mechanisms of Resistance to Drug for Triple-Negative Breast Cancer IdentifiedAugust 17th, 2021- Researchers Identify Mechanisms of Resistance to Drug for Triple-Negative Breast CancerAugust 17th, 2021
- Scientists Discover How Triple-Negative Breast Cancer Can Defeat Powerful DrugsAugust 16th, 2021
- Join now to see all
Grant Support
- P63 Mechanisms And Mediators In HnsccNational Institute Of Dental &Craniofacial Research2011
- Function And Mechanism Of REDD1 Signaling To TSC1/2 And MTORC1National Cancer Institute2007–2011
- P63 Mediators As Therapeutic Targets In HnsccNational Institute Of Dental &Craniofacial Research2004–2010
- Telomerase Functions In Differentiation &TransformationNational Cancer Institute1999–2003
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
